Cargando…
Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target
Autores principales: | Alatrash, Gheath, Garber, Haven R., Zhang, Mao, Sukhumalchandra, Pariya, Qiu, Yihua, Jakher, Haroon, Perakis, Alexander A., Becker, Lisa, Yoo, Suk Young, Dwyer, Karen C., Coombes, Kevin, Talukder, Amjad H., John, Lisa S. St, Senyukov, Vladimir, Lee, Dean A., Sergeeva, Anna, He, Hong, Ma, Qing, Armistead, Paul M., Roszik, Jason, Mittendorf, Elizabeth A., Molldrem, Jeffrey J., Hawke, David, Lizee, Gregory, Kornblau, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215491/ https://www.ncbi.nlm.nih.gov/pubmed/27573556 http://dx.doi.org/10.1038/leu.2016.249 |
Ejemplares similares
-
Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target
por: Khan, Maliha, et al.
Publicado: (2018) -
Adoptive T-cell therapy for Leukemia
por: Garber, Haven R, et al.
Publicado: (2014) -
Targeting cathepsin G in myeloid leukemia
por: Alatrash, Gheath
Publicado: (2013) -
Activity of 8F4, a T cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo
por: Sergeeva, Anna, et al.
Publicado: (2016) -
A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2
por: Herrmann, Amanda C., et al.
Publicado: (2019)